当前位置：
首页
>
产品中心 >
monoclonal_antibody >
Hytcult Biotech/Properdin，人，单克隆抗体1G6D2，功能研究抗体，低内毒素/HM2354-FS/0.5 mg
Hytcult Biotech/Properdin，人，单克隆抗体1G6D2，功能研究抗体，低内毒素/HM2354-FS/0.5 mg
商品编号：
HM2354-FS
品牌：
hycultbiotech
市场价：
¥19640.00
美元价：
11784.00
产品分类：
单克隆抗体
公司分类：
monoclonal_antibody
联系Q Q：
3392242852
电话号码：
4000-520-616
电子邮箱：
info@ebiomall.com
商品介绍
Description:Properdin,Human,mAb1G6D2,functionalstudyantibody,lowendotoxin
Monoclonalantibody1G6D2recognizeshumanproperdin,alsocalledcomplementfactorP.Thecomplementsystemisthefirstlineofdefenseagainstpathogensandfacilitateseliminationofapoptoticanddamagedcells.Positiveregulatorplasmaproteinproperdiniscriticalforthealternativepathwayofcomplement.Itisasingle-chainglycoprotein(ca53kDa)consistingofsixTSRsequences.Intheblooditexistsasamixtureofpreferablyhead-to-tailtrimers,butalsodimersandtetramers.Theproteinisproducedbyleukocytes,likeactivatedneutrophilsmonocytesandT-lymphocytes,butalsobyeg.stressedendothelialcells.
ProperdincanbothinitiateandpositivelyregulatethealternativepathwayactivitytogetherwithC3andfactorsB,D,IandH.ItbindstoC3bwhereItstABIlizesthelabileC3bBbconvertasewhichisdepositedonimmunecomplexesorforeignsurfaces.TherebyenhancingtheAPbystimulationofamplificationofC3bBb-convertaseformationincompetitionwithcatabolismofC3bbyfactorI,whichusesfactorHasacofactor.ThelocalamplificationprocessleadstothecreationofthealternativepathwayC5convertase,C3bBb3b,andinitiatestheterminalpathwayofcomplementactivation.Thealternativepathwaymayaccountforca80%oftheterminalpathwayactivity.ProperdinhasalsobeenshowntodirectlylimitfactorHactivity.
Recentstudiesshowthatproperdinisalsoapattern-recognitionreceptor(PRR)abletobinddirectlytomicrobialsurfaces,apoptoticandnecroticcells(dangerousnonselfandalteredself).Inappropriateactivationordysregulationofthealternativepathwayisacriticalfactorindevelopmentofseveralautoimmuneconditions.Targetsopsonizedwithproperdinarelabeledforclearancebyscavengercells,evenwithoutcomplement.Thismakesitapotentialtherapeutictargetindiseases.Recentstudieshasshownrenewedinterestintheevaluatingroleofproperdinindiseasepathogenesis,likeAsthma,arthritis,septicshock,AMDandC3glomerulopathy.
Antibody1G6D2canbeusedinELISA,westernblotting(onlynon-reduced)andasnegativecontrolantibodyforfunctionalstudiesinhibitingthealternativepathwayofcomplement(Ref1).
ProperdincanbothinitiateandpositivelyregulatethealternativepathwayactivitytogetherwithC3andfactorsB,D,IandH.ItbindstoC3bwhereItstABIlizesthelabileC3bBbconvertasewhichisdepositedonimmunecomplexesorforeignsurfaces.TherebyenhancingtheAPbystimulationofamplificationofC3bBb-convertaseformationincompetitionwithcatabolismofC3bbyfactorI,whichusesfactorHasacofactor.ThelocalamplificationprocessleadstothecreationofthealternativepathwayC5convertase,C3bBb3b,andinitiatestheterminalpathwayofcomplementactivation.Thealternativepathwaymayaccountforca80%oftheterminalpathwayactivity.ProperdinhasalsobeenshowntodirectlylimitfactorHactivity.
Recentstudiesshowthatproperdinisalsoapattern-recognitionreceptor(PRR)abletobinddirectlytomicrobialsurfaces,apoptoticandnecroticcells(dangerousnonselfandalteredself).Inappropriateactivationordysregulationofthealternativepathwayisacriticalfactorindevelopmentofseveralautoimmuneconditions.Targetsopsonizedwithproperdinarelabeledforclearancebyscavengercells,evenwithoutcomplement.Thismakesitapotentialtherapeutictargetindiseases.Recentstudieshasshownrenewedinterestintheevaluatingroleofproperdinindiseasepathogenesis,likeAsthma,arthritis,septicshock,AMDandC3glomerulopathy.
Antibody1G6D2canbeusedinELISA,westernblotting(onlynon-reduced)andasnegativecontrolantibodyforfunctionalstudiesinhibitingthealternativepathwayofcomplement(Ref1).
Specifications:
| Catalognumber | HM2354-FS |
|---|---|
| Producttype | Monoclonalantibodies |
| Quantity | 0.5mg |
| Formulation | 0.5mg(100μg/ml)0.2μmfilteredantibodysolutioninPBS(exactconcentrationisindicatedonthelabel). |
| Application | Functionalstudies,Immunoassays,Westernblot |
| ApplicationNotes | W:Anon-reducedsampletreatmentwasused.Thebandsizeis52kDa. FS:InhibitionofthealternativecomplementpathwaytestedwithHM2354asacontrolfornotinhibitingandHM2355asaninhibitionantibody.Differentconcentrationshavebeentested(0–5μg/ml). |
| Immunogen | Humanproperdinpurifiedfromhumanplasma. |
| Isotype | MouseIgG1 |
| Species | Human |
| Alias | ComplementfactorP Genename:CFP,PFC |
| PositiveControl | HM2355:Properdin,Human,clone3A3E1 |
| NegativeControl | HM2354:Properdin,Human,clone1G6D2 |
| References | 1.BlattAetal;Properdin-mediatedC5aproductionenhancesstablebindingofplateletstogranulocytesinhumanwholeblood.JImmunol2016;196:4671 |
| Storageandstability | Productshouldbestoredat4°C.Underrecommendedstorageconditions,productisstableforoneyear. |
| Precautions | Forresearchuseonly.Notforuseinoronhumansoranimalsorfordiagnostics.Itistheresponsibilityoftheusertocomplywithalllocal/stateandfederalrulesintheuseofthisproduct.HycultBiotechisnotresponsIBLeforanypatentinfringementsthatmightresultfromtheuseorderivationofthisproduct. |
| Disease | Autoimmunity,Nephrology |
品牌介绍
荷兰HyCult Biotechnology(HBT)位于荷兰乌登，从1994开始制造检测抗体和蛋白质，主要侧重与病理学诊断有关的全套产品研发，既有纯化的重组蛋白和多肽，也有单抗和多抗，是世界一流的先天免疫领域的研究试剂制造商。
联络我们
